| Literature DB >> 33537300 |
Collin M Bantle1, Warren D Hirst1, Andreas Weihofen1, Evgeny Shlevkov1.
Abstract
Mitochondrial dysfunction is a hallmark of Parkinson's disease (PD). Astrocytes are the most abundant glial cell type in the brain and are thought to play a pivotal role in the progression of PD. Emerging evidence suggests that many astrocytic functions, including glutamate metabolism, Ca2+ signaling, fatty acid metabolism, antioxidant production, and inflammation are dependent on healthy mitochondria. Here, we review how mitochondrial dysfunction impacts astrocytes, highlighting translational gaps and opening new questions for therapeutic development.Entities:
Keywords: NLRP3; PINK1/Parkin pathway; Parkinson’s disease; astrocyte; cGAS/STING pathway; inflammation; mitochondria
Year: 2021 PMID: 33537300 PMCID: PMC7849831 DOI: 10.3389/fcell.2020.608026
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X